Characterization of the RNA silencing suppression activity of the ebola virus VP35 protein in plants and mammalian cells

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 3038-3049

  Zhu, Yali ^a   Cherukuri, Nil Celebi ^a   Jackel, Jamie N ^a,c   Wu, Zetang ^b,d   Crary, Monica ^a   Buckley, Kenneth J ^a   Bisaro, David M ^a,b,c   Parris, Deborah S ^a,b  

^a Center for RNA Biology   (United States)

^b Cellular   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROTEIN KINASE R; PROTEIN VP35; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; EBOLA VIRUS; GENE AMPLIFICATION; GENE SILENCING; GENETIC DAMAGE; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PLANT MICROORGANISM INTERACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; PROTEIN SYNTHESIS INHIBITION; RNA TRANSLATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; CELL LINE; CRICETINAE; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MAMMALS; MICRORNAS; NUCLEOPROTEINS; PROTEIN STRUCTURE, TERTIARY; RNA INTERFERENCE; TOBACCO; TRANSFECTION; VIRAL CORE PROTEINS;

EBOLA VIRUS; MAMMALIA;

EID: 84863280767     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05741-11     Document Type: Article

References (57)

1. Basler CF, Amarasinghe GK. 2009. Evasion of interferon responses by Ebola and Marburg viruses. J. Interferon Cytokine Res. 29:511-520.
2. Basler CF, et al. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77:7945-7956.
3. Basler CF, et al. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. U. S. A. 97:12289 -12294.
4. Brodersen P, Voinnet O. 2006. The diversity of RNA silencing pathways in plants. Trends Genet. 22:268 -280.
5. Bucher E, Hemmes H, de Haan P, Goldbach R, Prins M. 2004. The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants. J. Gen. Virol. 85:983-991.
6. Burgyan J, Havelda Z. 2011. Viral suppressors of RNA silencing. Trends Plant Sci. 16:265-272.
7. Cardenas WB, et al. 2006. Ebola virus VP35 protein binds doublestranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 80:5168 -5178.
8. Chang T-H, et al. 2009. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog. 5:e1000493.
9. Delgadillo MO, Saenz P, Salvador B, Gracia JA, Simon-Mateo C. 2004. Human influenza virus NS1 protein enhances viral pathogenicity and acts as an RNA silencing suppressor in plants. J. Gen. Virol. 85:993-999.
10. Diaz-Pendon JA, Ding S-W. 2008. Direct and indirect roles of viral suppressors of RNA silencing in pathogenesis. Annu. Rev. Phytopathol. 46:303-326.
11. Fabozzi G, Nabel CS, Dolan MA, Sullivan NJ. 2011. Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J. Virol. 85:2512-2523.
12. Feng Z, Cerveny M, Yan Z, He B. 2007. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J. Virol. 81:182-192.
13. Gale M, Jr, Katze MG. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferoninduced protein kinase. Pharmacol. Ther. 78:29-46.
14. Geisbert TW, et al. 2010. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 375:1896 -1905.
15. Haasnoot J, et al. 2007. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog. 3:e86.
16. Hamilton AJ, Baulcombe DC. 1999. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286:950 -952.
17. Harcourt BH, Sanchez A, Offermann MK. 1999. Ebola virus selectively inhibits responses to interferons, but not to interleukin-1b, in endothelial cells. J. Virol. 73:3491-3496.
18. Hartman AL, et al. 2008. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of Ebola virus. J. Virol. 82:2699 -2704.
19. Hartman AL, Towner JS, Nichol ST. 2004. A C-terminal basic amino acid motif of Zaire Ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. Virology 328: 177-184.
20. Hensley LE, Jones SM, Feldmann H, Jahrling PB, Geisbert TW. 2005. Ebola and Marburg viruses: pathogenesis and development of countermeasures. Curr. Mol. Med. 5:761-772.
21. Huang Y, Xu L, Sun Y, Nabel G. 2002. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol. Cell 10:307-316.
22. Jahrling PB, et al. 1999. Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J. Infect. Dis. 179:S224 -S234.
23. Johansen LK, Carrington JC. 2001. Silencing on the spot: induction and suppression of RNA silencing in the Agrobacterium-mediated transient expression system. Plant Physiol. 126:930 -938.
24. Kash JC, et al. 2006. Global suppression of the host antiviral response by Ebola- and Margviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J. Virol. 80:3009 -3020.
25. Kasschau KD, et al. 2003. P1/HC-Pro, a viral suppressor of RNA silencing, interferes with Arabidopsis development and microRNA function. Dev. Cell 4:205-217.
26. Kimberlin CR, et al. 2010. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc. Natl. Acad. Sci. U. S. A. 107:314 -319.
27. Kobinger GP, et al. 2006. Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. Virology 346:394-401.
28. Lakatos L, et al. 2006. Small RNA binding is a common strategy to suppress RNA silencing by several viral suppressors. EMBO J. 25:2768- 2780.
29. Leung DW, et al. 2009. Structure of the Ebola VP35 interferon inhibitory domain. Proc. Natl. Acad. Sci. U. S. A. 106:411- 416.
30. Leung DW, et al. 2010. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat. Struct. Mol. Biol. 17:165- 172.
31. Li F, Ding S-W. 2006. Virus counterdefense: diverse strategies for evading the RNA-silencing immunity. Annu. Rev. Microbiol. 60:503-531.
32. Li S, et al. 2006. Molecular basis for PKR activation by PACT or dsRNA. Proc. Natl. Acad. Sci. U. S. A. 103:10005-10010.
33. Li W-X, et al. 2004. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc. Natl. Acad. Sci. U. S. A. 101:1350 -1355.
34. Marques JT, Carthew RW. 2007. A call to arms: coevolution of animal viruses and host innate immune responses. Trends Genet. 23:359 -364.
35. McManus MT, Sharp PA. 2002. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3:737-747.
36. Muhlberger E, Lotfering B, Klenk H-D, Becker S. 1998. Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes. J. Virol. 72:8756-8764.
37. Muhlberger E, Weik M, Volchkov VE, Klenk H-D, Becker S. 1999. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J. Virol. 73: 2333-2342.
38. Prins KC, Cardenas WB, Basler CF. 2009. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKε and TBK-1. J. Virol. 83:3069 -3077.
39. Qian S, et al. 2009. HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. Proc. Natl. Acad. Sci. U. S. A. 106:605- 610.
40. Raja P, Wolf JN, Bisaro DM. 2010. RNA silencing directed against geminiviruses: post-transcriptional and epigenetic components. Biochim. Biophys. Acta 1799:337-351.
41. Richardson JS, et al. 2009. Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine. PLoS One 4:e5308.
42. Ruiz MT, Voinnet O, Baulcombe DC. 1998. Initiation and maintenance of virus-induced gene silencing. Plant Cell 10:937-946.
43. Saksela K. 2003. Human viruses under attack by small inhibitory RNA. Trends Microbiol. 11:345-347.
44. Saumet A, Lecellier C-H. 2006. Anti-viral RNA silencing: do we look like plants? Retrovirology 3:3-14.
45. Schumann M, Gantke T, Muhlberger E. 2009. Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J. Virol. 83:8993- 8997.
46. Silhavy D, et al. 2002. A viral protein suppresses RNA silencing and binds silencing-generated 21- to 25-nucleotide double-stranded RNAs. EMBO J. 21:3070 -3080.
47. Sun Y, et al. 2009. Protection against lethal challenge by Ebola virus-like particles produced in insect cells. Virology 383:12-21.
48. Voinnet O. 2005. Induction and suppression of RNA silencing: insights from viral infections. Nat. Rev. Genet. 6:206-220.
49. Wang H, Buckley KJ, Yang X, Buchmann RC, Bisaro DM. 2005. Adenosine kinase inhibition and suppression of RNA silencing by geminivirus AL2 and L2 proteins. J. Virol. 79:7410-7418.
50. Warren TK, et al. 2010. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat. Med. 16:991-994.
51. Wu Z, Zhu Y, Bisaro DM, Parris DS. 2009. Herpes simplex virus type 1 suppresses RNA-induced gene silencing in mammalian cells. J. Virol. 83: 6652-6663.
52. Yao F, Winkler STT, Lu M, Eriksson C, Eriksson E. 1998. Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum. Gene Ther. 9:1939 -1950.
53. Yao F, Theopold C, Hoeller D, Bleiziffer O, Lu Z. 2006. Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector. Mol. Ther. 13:1133-1141.
54. Yi R, Qin Y, Macara IG, Cullen BR. 2003. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17:3011-3016.
55. Zamore PD, Tuschl T, Sharp PA, Bartel DP. 2000. RNAi: dsRNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25-33.
56. Zeng Y, Cullen BR. 2003. Sequence requirements for micro RNA processing and function in human cells. RNA 9:112-123.
57. Zeng Y, Yi R, Cullen BR. 2003. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl. Acad. Sci. U. S. A. 100:9779 -9784.